Antimicrobial Agents and Chemotherapy · 1993 · 184 citations · 27 references
DysbiosisGastroenterologyAntimicrobial ChemotherapyBroad-spectrum AntibioticsDrug ResistanceInfection ControlAnti-infective AgentsMouse ModelAntimicrobial ResistanceHealth SciencesProspective EvaluationGastrointestinal Yeast ColonizationMicrobiomePharmacologyClinical MicrobiologyAntimicrobial SusceptibilityAntibioticsYeast FloraMicrobiologyMedicine
This study evaluated the effects of broad-spectrum antibiotics on the gastrointestinal (G.I.) yeast flora of humans and correlated the findings with those obtained from a mouse model of G.I. colonization by Candida albicans. We prospectively studied 46 adult cancer patients who received one of five broad-spectrum antibiotics (ceftriaxone, ceftazidime, ticarcillin-clavulanic acid, imipenem-cilastatin, and aztreonam) as therapy for infections. Quantitative examination of yeast colonization of stools was conducted at the baseline, at the end of antibiotic treatment, and 1 week after discontinuation of therapy. Antibiotics with anaerobic activity (ticarcillin-clavulanic acid) or high G.I. concentrations (ceftriaxone) caused a higher and more sustained increase in G.I. colonization by yeasts than did antibiotics with poor anaerobic activity (ceftazidime and aztreonam) or a low G.I. concentration (imipenem-cilastatin). These results were similar to those obtained with a mouse model of G.I. colonization by C. albicans that involved the same antibiotics. Hence, the mouse model may be useful for evaluation of yeast colonization of the human G.I. tract.
27
New Spectrum of Fungal Infections in Patients with Cancer
E. Anaissie, Gerald P. Bodey, Hagop Kantarjian et al. · Clinical Infectious Diseases · 1989 · 262 citations
Candidiasis in cancer patients.
S. Zai, Shireen Khan, Jawad A Gillani · PubMed · 1997 · 251 citations
H. Harlan Stone, LAURA D. KOLB, CAMILLA A. CURRIE et al. · Annals of Surgery · 1974 · 226 citations · Full text